467 related articles for article (PubMed ID: 17322495)
1. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
[TBL] [Abstract][Full Text] [Related]
3. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
4. Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment.
Meazza C; Elsedfy HH; Pagani S; Bozzola E; El Kholy M; Bozzola M
Horm Metab Res; 2014 Mar; 46(3):219-23. PubMed ID: 24297484
[TBL] [Abstract][Full Text] [Related]
5. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
6. Effects of growth hormone therapy on metabolic parameters, adipokine and endothelial dysfunction in prepuberal children.
Cañete MD; Valle-Martos R; Martos R; Cañete R; Valle M; Jiménez-Reina L
Acta Paediatr; 2019 Nov; 108(11):2027-2033. PubMed ID: 31087421
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.
López-Siguero JP; López-Canti LF; Espino R; Caro E; Fernández-García JM; Gutiérrez-Macías A; Rial JM; Lechuga JL; Macías F; Martínez-Aedo MJ; Rico S; Rodríguez I; Guillén J; Arroyo FJ; Bernal S; Espigares R; Núñez M; Escribano A; Barrionuevo JL; Gentil J; Barrios V; Fernández-Nistal A; Martos-Moreno GA; Martínez V; Argente J
J Endocrinol Invest; 2011 Apr; 34(4):300-6. PubMed ID: 20634639
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins.
Lanes R; Soros A; Gunczler P; Paoli M; Carrillo E; Villaroel O; Palacios A
J Pediatr; 2006 Sep; 149(3):324-9. PubMed ID: 16939741
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular risk of GH-deficient adolescents.
Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
[TBL] [Abstract][Full Text] [Related]
11. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
12. Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study.
Capalbo D; Mattace Raso G; Esposito A; Di Mase R; Barbieri F; Meli R; Bruzzese D; Salerno M
Clin Endocrinol (Oxf); 2014 Jun; 80(6):856-62. PubMed ID: 24372071
[TBL] [Abstract][Full Text] [Related]
13. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
14. Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.
Joaquin C; Aguilera E; Granada ML; Pastor MC; Salinas I; Alonso N; Sanmartí A
Eur J Endocrinol; 2008 Apr; 158(4):483-90. PubMed ID: 18362295
[TBL] [Abstract][Full Text] [Related]
15. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
[TBL] [Abstract][Full Text] [Related]
16. Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapy.
De Marco S; Marcovecchio ML; Caniglia D; De Leonibus C; Chiarelli F; Mohn A
Growth Horm IGF Res; 2014 Oct; 24(5):216-20. PubMed ID: 25172154
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
[TBL] [Abstract][Full Text] [Related]
18. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two dose regimens of growth hormone (GH) with different target IGF-1 levels on glucose metabolism, lipid profile, cardiovascular function and anthropometric parameters in gh-deficient adults.
Cenci MC; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M; Boguszewski CL; Conceição FL
Growth Horm IGF Res; 2012; 22(3-4):116-21. PubMed ID: 22565153
[TBL] [Abstract][Full Text] [Related]
20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
